350 related articles for article (PubMed ID: 26393560)
1. Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes.
Dragutan I; Dragutan V; Demonceau A
Molecules; 2015 Sep; 20(9):17244-74. PubMed ID: 26393560
[TBL] [Abstract][Full Text] [Related]
2. Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry.
Thota S
Mini Rev Med Chem; 2016; 16(10):771. PubMed ID: 27161007
[No Abstract] [Full Text] [Related]
3. Half-sandwich arene ruthenium complexes: synthetic strategies and relevance in catalysis.
Kumar P; Gupta RK; Pandey DS
Chem Soc Rev; 2014 Jan; 43(2):707-33. PubMed ID: 24193103
[TBL] [Abstract][Full Text] [Related]
4. Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents.
Pal M; Nandi U; Mukherjee D
Eur J Med Chem; 2018 Apr; 150():419-445. PubMed ID: 29547831
[TBL] [Abstract][Full Text] [Related]
5. Development of Arene Ruthenium Antitumor Complexes.
Su W; Tang Z; Li P
Mini Rev Med Chem; 2016; 16(10):787-95. PubMed ID: 27161008
[TBL] [Abstract][Full Text] [Related]
6. Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy.
Liu J; Lai H; Xiong Z; Chen B; Chen T
Chem Commun (Camb); 2019 Aug; 55(67):9904-9914. PubMed ID: 31360938
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in ruthenium anticancer drugs.
Levina A; Mitra A; Lay PA
Metallomics; 2009 Nov; 1(6):458-70. PubMed ID: 21305154
[TBL] [Abstract][Full Text] [Related]
8. Photoactivation of Anticancer Ru Complexes in Deep Tissue: How Deep Can We Go?
Sun W; Thiramanas R; Slep LD; Zeng X; Mailänder V; Wu S
Chemistry; 2017 Aug; 23(45):10832-10837. PubMed ID: 28564102
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
[TBL] [Abstract][Full Text] [Related]
10. Bioorthogonal Catalytic Activation of Platinum and Ruthenium Anticancer Complexes by FAD and Flavoproteins.
Alonso-de Castro S; Cortajarena AL; López-Gallego F; Salassa L
Angew Chem Int Ed Engl; 2018 Mar; 57(12):3143-3147. PubMed ID: 29359850
[TBL] [Abstract][Full Text] [Related]
11. Strained ruthenium complexes are potent light-activated anticancer agents.
Howerton BS; Heidary DK; Glazer EC
J Am Chem Soc; 2012 May; 134(20):8324-7. PubMed ID: 22553960
[TBL] [Abstract][Full Text] [Related]
12. Theoretical study of the electronic and spectroscopic properties of some Ru(II) anticancer complexes.
Adeniyi AA; Ajibade PA
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Mar; 105():456-65. PubMed ID: 23348198
[TBL] [Abstract][Full Text] [Related]
13. Arene Ruthenium(II) Complexes with Phosphorous Ligands as Possible Anticancer Agents.
Biancalana L; Pampaloni G; Marchetti F
Chimia (Aarau); 2017 Sep; 71(9):573-579. PubMed ID: 30188287
[TBL] [Abstract][Full Text] [Related]
14. Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.
Tripathy SK; De U; Dehury N; Pal S; Kim HS; Patra S
Dalton Trans; 2014 Oct; 43(39):14546-9. PubMed ID: 25160655
[TBL] [Abstract][Full Text] [Related]
15. Half-sandwich Ru(II) N-heterocyclic carbene complexes in anticancer drug design.
Lenis Rojas OA; Cordeiro S; Baptista PV; Fernandes AR
J Inorg Biochem; 2023 Aug; 245():112255. PubMed ID: 37196411
[TBL] [Abstract][Full Text] [Related]
16. Beyond catalysis: N-heterocyclic carbene complexes as components for medicinal, luminescent, and functional materials applications.
Mercs L; Albrecht M
Chem Soc Rev; 2010 Jun; 39(6):1903-12. PubMed ID: 20502793
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a strongly apoptotic ruthenium complex through combinatorial coordination chemistry.
Mulcahy SP; Gründler K; Frias C; Wagner L; Prokop A; Meggers E
Dalton Trans; 2010 Sep; 39(35):8177-82. PubMed ID: 20689887
[TBL] [Abstract][Full Text] [Related]
18. Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.
Dubarle-Offner J; Clavel CM; Gontard G; Dyson PJ; Amouri H
Chemistry; 2014 May; 20(19):5795-801. PubMed ID: 24668791
[TBL] [Abstract][Full Text] [Related]
19. Metallomics for drug development: a further insight into intracellular activation chemistry of a ruthenium(III)-based anticancer drug gained using a multidimensional analytical approach.
Matczuk M; Prządka M; Aleksenko SS; Czarnocki Z; Pawlak K; Timerbaev AR; Jarosz M
Metallomics; 2014 Jan; 6(1):147-53. PubMed ID: 24247321
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial fragmentation is an important cellular event induced by ruthenium(II) polypyridyl complexes in osteosarcoma cells.
Du Y; Fu X; Li H; Chen B; Guo Y; Su G; Zhang H; Ning F; Lin Y; Mei W; Chen T
ChemMedChem; 2014 Apr; 9(4):714-8. PubMed ID: 24403015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
